This comprehensive series explores the promising use of ketamine as an off-label treatment for treatment-resistant depression. Written by Dr. Chittaranjan Andrade, the articles detail how ketamine differs from conventional antidepressants by producing rapid and significant improvement (within hours). The series provides clinicians with practical guidance on this novel antidepressant approach that shows particular promise for patients who haven't responded to traditional treatments.